The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
Open accessAbstract
OBJECTIVES: To examine the risk of atrial fibrillation in relation to the whole spectrum of thyroid function in a large cohort of patients. DESIGN: Population based cohort study of general practice patients identified by linkage of nationwide registries at the individual level. SETTING: Primary care patients in the city of Copenhagen. SUBJECTS: Registry data for 586,460 adults who had their thyroid function evaluated for the first time by their general practitioner during 2000-10 and who were without previously recorded thyroid disease or atrial fibrillation. MAIN OUTCOME MEASURE: Poisson regression models used to estimate risk of atrial fibrillation by thyroid function. RESULTS: Of the 586,460 individuals in the study population (mean (SD) age 50.2 (16.9) years, 39% men), 562,461 (96.0%) were euthyroid, 1670 (0.3%) had overt hypothyroidism, 12,087 (2.0%) had subclinical hypothyroidism, 3966 (0.7%) had overt hyperthyroidism, and 6276 (1.0%) had subclinical hyperthyroidism. Compared with the euthyroid individuals, the risk of atrial fibrillation increased with decreasing levels of thyroid stimulating hormone (TSH) from high normal euthyroidism (incidence rate ratio 1.12 (95% CI 1.03 to 1.21)) to subclinical hyperthyroidism with reduced TSH (1.16 (0.99 to 1.36)) and subclinical hyperthyroidism with supressed TSH (1.41 (1.25 to 1.59)). Both overt and subclinical hypothyroidism were associated with a lower risk of atrial fibrillation. CONCLUSION: The risk of atrial fibrillation was closely associated with thyroid activity, with a low risk in overt hypothyroidism, high risk in hyperthyroidism, and a TSH level dependent association with risk of atrial fibrillation across the spectrum of subclinical thyroid disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, a TSH level-dependent association with the risk of AF was found across the whole spectrum of thyroid function in a large population-based cohort study [74] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Compared to euthyroid individuals (TSH: 0.4-5 mIU/l), the risk of AF increased with decreasing levels of serum TSH from high-normal thyroid function [TSH: 0.2-0.4mIU/l; adjusted incidence rate ratio (IRR) = 1.12] to mild SHyper (TSH: 0.1-0.2mIU/l; IRR = 1.16) and grade 2 SHyper (TSH: <0.1 mIU/l; IRR = 1.41) [74] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [74]
In the citing paper
“Similar trends were seen for men.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [401]
In the citing paper
“Sawin et al. (399) first reported a 2.8-fold increased risk of atrial fibrillation in SH subjects over age 60 years in 1994, and subsequent studies have confirmed that the risk of arrhythmias, particularly atrial fibrillation, is increased in SH (381,384,388,391,400,401).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [401]
In the citing paper
“However, absolute incidence rates of atrial fibrillation were much lower in younger subjects; for example, women under the age of 65 years had atrial fibrillation incidence rates of 2.3 events per 1000 personyears (relative risk of 1.89 compared to age-matched euthyroid women), while women 65 years and older had incidence rates of 22.7 per 1000 person-years (relative risk of 1.27 compared to age-”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [401]
In the citing paper
“In the largest study to date (586,460 people followed for a median of 5.5 years), the highest relative risk for atrial fibrillation occurred in younger subjects, possibly because other causes predominate with age, and in subjects with lower TSH levels (401).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [401]
In the citing paper
“Some of these studies re-ported increased risks of overall mortality in older subjects (380,429), cardiovascular events (391), heart failure (381), and atrial fibrillation in all subjects (401) or in older subjects (384), and vertebral fractures in older women (408).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [401]
In the citing paper
“Thyroid dysfunction 206, 207 hypothyroidism subclinical hyperthyroidism overt hyperthyroidism (reference: euthyroid) HR 1.23 (95% CI 0.77-1.97)RR 1.31 (95% CI 1.19-1.44)RR 1.42 (95% CI 1.22-1.63)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [206]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
The Danish Civil Registration System
Pedersen, C. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,713
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
The Danish National Prescription Registry
Wallach‐Kildemoes, H., Sørensen, H. T., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,490
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
The Danish Register of Causes of Death
Helweg‐Larsen, K. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399958 · Cited by 1,735
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.2307/2670170 · Cited by 1,375
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
Research works printed but not linked: 1
- [27]Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012; 172: 799-809. 22529182 PMC3872478
Cited by
Sorted by citations
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Gelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,594
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“Some of these studies reported increased risks of overall mortality in older subjects (380,429), cardiovascular events (391), heart failure (381), and atrial fibrillation in all subjects (401) or in older subjects (384), and vertebral fractures in older women (408).”
Background2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Gharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedűs, L. D., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,285
The Clinical Profile and Pathophysiology of Atrial Fibrillation
Andrade, J. G., Khairy, P., Dobrev, D., & Nattel, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.303211 · Cited by 1,232
Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Andrade, J. G., Aguilar, M., Atzema, C. L., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 593
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis
Ko, D., Rahman, F., Schnabel, R. B., Yin, X., Benjamin, E. J., & Christophersen, I. E. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.45 · Cited by 353
The physiology of endocrine systems with ageing
van den Beld, A. W., Kaufman, J.-M., Zillikens, M. C., Lamberts, S. W. J., Egan, J. M., & van der Lely, A. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30026-3 · Cited by 349
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Udovcic, M., Pena, R. H., Patham, B., Tabatabai, L. S., & Kansara, A. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-2-55 · Cited by 308
Selmer, C., Olesen, J. B., Hansen, M. L., von Kappelgaard, L. M., Madsen, J. C., Hansen, P. R., Pedersen, O. D., Faber, J., Torp-Pedersen, C., & Gislason, G. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4184 · Cited by 288
Self-citationBaumgartner, C., da Costa, B. R., Collet, T., Feller, M., Floriani, C., Bauer, D. C., Cappola, A. R., Heckbert, S. R., Ceresini, G., Gussekloo, J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028753 · Cited by 256
Medici, M., Porcu, E., Pistis, G., Teumer, A., Brown, S. J., Jensen, R. A., Rawal, R., Roef, G. L., Plantinga, T. S., Vermeulen, S. H., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004123 · Cited by 218
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy
Antonelli, A., Fallahi, P., Elia, G., Ragusa, F., Paparo, S. R., Ruffilli, I., Patrizio, A., Gonnella, D., Giusti, C., Virili, C., et al. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101388 · Cited by 201
Osuna, P. M., Udovcic, M., & Sharma, M. D. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-2-60 · Cited by 199
Effects of thyroid hormones on the heart
Vargas‐Uricoechea, H., Bonelo, A., & Sierra-Torres, C. H. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.07.003 · Cited by 193
Ehrenkranz, J., Bach, P. R., Snow, G. L., Schneider, A., Lee, J. L., Ilstrup, S., Bennett, S. T., & Benvenga, S. (2015) · Thyroid · doi:10.1089/thy.2014.0589 · Cited by 190
Cadby, G., McArdle, N., Briffa, T., Hillman, D. R., Simpson, L., Knuiman, M., & Hung, J. (2015) · Chest · doi:10.1378/chest.15-0229 · Cited by 184
Are cardiovascular risk factors also associated with the incidence of atrial fibrillation?
Allan, V., Honarbakhsh, S., Casas, J. P., Wallace, J., Hunter, R. J., SCHILLING, R. J., Perel, P., Morley, K. I., Banerjee, A., & Hemingway, H. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-11-0825 · Cited by 188
Lillevang-Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedüs, L. (2018) · Thyroid · doi:10.1089/thy.2017.0517 · Cited by 150
Ning, Y., Cheng, Y. J., Liu, L. J., Sara, J. D. S., Cao, Z. Y., Zheng, W. P., Zhang, T. S., Han, H. J., Yang, Z. Y., Zhang, Y., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0777-9 · Cited by 148
Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066711 · Cited by 142
Odening, K. E., Deiß, S., Dilling-Boer, D. M., Didenko, M., Eriksson, U., Nedios, S., Ng, F. S., Roca‐Luque, I., Borque, P. S., Vernooy, K., et al. (2018) · EP Europace · doi:10.1093/europace/euy215 · Cited by 138
Biondi, B., & Cooper, D. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709318 · Cited by 135
Atrial fibrillation and hyperthyroidism: A literature review
Reddy, V. Y., Taha, W. S., Kundumadam, S. D., & Khan, M. R. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.07.004 · Cited by 135
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · EP Europace · doi:10.1093/europace/euw242 · Cited by 134
The influence of thyroid function on the coagulation system and its clinical consequences
Elbers, L. P. B., Fliers, E., & Cannegieter, S. C. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13970 · Cited by 123
Knuiman, M. W., Briffa, T. G., Divitini, M., Chew, D. P., Eikelboom, J. W., McQuillan, B., & Hung, J. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-013-9875-y · Cited by 125
Hyperthyroidism: Diagnosis and Treatment.
Kravets, I. (2016) · PubMed · Cited by 122
Gender differences in thyroid system function: relevance to bipolar disorder and its treatment
Bauer, M., Glenn, T., Pilhatsch, M., Pfennig, A., & Whybrow, P. C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12150 · Cited by 126
Ellervik, C., Roselli, C., Christophersen, I. E., Alonso, Á., Pietzner, M., Sitlani, C. M., Trompet, S., Arking, D. E., Geelhoed, B., Guo, X., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2018.4635 · Cited by 109
Both Hypothyroidism and Hyperthyroidism Increase Atrial Fibrillation Inducibility in Rats
Zhang, Y., Dedkov, E. I., Teplitsky, D., Weltman, N. Y., Pol, C. J., Rajagopalan, V., Lee, B., & Gerdes, A. M. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000502 · Cited by 104
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 104
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 106
Lillevang‐Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedűs, L. D. (2019) · Thyroid · doi:10.1089/thy.2018.0320 · Cited by 103
Lillevang-Johansen, M., Abrahamsen, B., Jørgensen, H. L., Brix, T. H., & Hegedüs, L. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0006 · Cited by 100
Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study
Chaker, L., Heeringa, J., Dehghan, A., Medici, M., Visser, W. E., Baumgartner, C., Albert Hofman, D., Rodondi, N., Peeters, R. P., & Franco, O. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2480 · Cited by 100
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Paradoxical Association of Lipoprotein Measures With Incident Atrial Fibrillation
Mora, S., Akinkuolie, A. O., Sandhu, R. K., Conen, D., & Albert, C. M. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.001378 · Cited by 98
Mammen, J. S., McGready, J., Oxman, R., Chia, C. W., Ladenson, P. W., & Simonsick, E. M. (2015) · Thyroid · doi:10.1089/thy.2015.0180 · Cited by 94
Morley, K. I., Wallace, J., Denaxas, S., Hunter, R. J., Patel, R. S., Perel, P., Shah, A. D., Timmis, A., SCHILLING, R. J., & Hemingway, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110900 · Cited by 96
Thvilum, M., Brandt, F., Almind, D., Christensen, K., Brix, T. H., & Hegedüs, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075789 · Cited by 92
Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study
Pearce, S. H. S., Razvi, S., Yadegarfar, M. E., Martin-Ruiz, C., Kingston, A., Collerton, J., Visser, T. J., Kirkwood, T. B., & Jagger, C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1935 · Cited by 91
Diagnosis and management of thyrotoxicosis
Vaidya, B., & Pearce, S. H. S. (2014) · BMJ · doi:10.1136/bmj.g5128 · Cited by 91
Subclinical hypothyroidism: summary of evidence in 2014
Baumgartner, C., Blum, M. R., & Rodondi, N. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14058 · Cited by 90
The Normal TSH Reference Range: What Has Changed in the Last Decade?
Biondi, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2760 · Cited by 88
Fitzgerald, S. P., Bean, N. G., Falhammar, H., & Tuke, J. (2020) · Thyroid® · doi:10.1089/thy.2019.0535 · Cited by 86
Incidence and Predictors of Atrial Fibrillation Progression
Blum, S., Aeschbacher, S., Meyre, P. B., Zwimpfer, L., Reichlin, T., Beer, J. H., Ammann, P., Auricchio, A., Kobza, R., Erné, P., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012554 · Cited by 87
Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
Carnagarin, R., Kiuchi, M. G., Ho, J. K., Matthews, V. B., & Schlaich, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01058 · Cited by 81
Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?
Manolis, A. S., Manolis, T. A., Melita, H., & Manolis, A. S. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.02.011 · Cited by 81
Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study)
Kim, E.-J., Lyass, A., Wang, N., Massaro, J. M., Fox, C. S., Benjamin, E. J., & Magnani, J. W. (2014) · American Heart Journal · doi:10.1016/j.ahj.2013.10.012 · Cited by 80
Chen, D., Lin, C., Chen, Y., & Chen, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165601 · Cited by 80
Sterenborg, R. B. T. M., Steinbrenner, I., Li, Y., Bujnis, M. N., Naito, T., Marouli, E., Galesloot, T. E., Babajide, O., Andreasen, L., Astrup, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44701-9 · Cited by 79
Self-citationBarbesino, G. (2018) · Gerontology · doi:10.1159/000490911 · Cited by 73
Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis
Chaker, L., Baumgartner, C., Ikram, M. A., Dehghan, A., Medici, M., Visser, W. E., Hofman, A., Rodondi, N., Peeters, R. P., & Franco, O. H. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9946-8 · Cited by 72
Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule
Treglia, G., Trimboli, P., Verburg, F. A., Luster, M., & Giovanella, L. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12456 · Cited by 67
Recent Advances in Autoimmune Thyroid Diseases
Yoo, W. S., & Chung, H. K. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.3.379 · Cited by 66
Thyroid hormones and the heart
Vargas‐Uricoechea, H., & Sierra-Torres, C. H. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0059 · Cited by 65
Sohn, S. Y., Lee, E., Lee, M. K., & Lee, J. H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.728 · Cited by 60
Ahmadi, N., Ahmadi, F., Sadiqi, M., Ziemnicka, K., & Mińczykowski, A. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0052 · Cited by 58
Ryödi, E., Metso, S., Huhtala, H., Välimäki, M. J., Auvinen, A. P., & Jaatinen, P. (2018) · Thyroid · doi:10.1089/thy.2017.0461 · Cited by 58
Atrial Fibrillation and Race – A Contemporary Review
Amponsah, M., Benjamin, E. J., & Magnani, J. W. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0327-8 · Cited by 55
Pediatric papillary thyroid cancer: current management challenges
Verburg, F. A., van Santen, H. M., & Luster, M. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s100512 · Cited by 55
Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases
Larsson, S. C., Allara, E., Mason, A. M., Michaëlsson, K., & Burgess, S. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002468 · Cited by 55
Subclinical Hyperthyroidism and the Cardiovascular Disease
Delitala, A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-117893 · Cited by 51
Risk factors for new-onset atrial fibrillation: A focus on Asian populations
Li, Y., Pastori, D., Guo, Y., Wang, Y., & Lip, G. Y. H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.051 · Cited by 49
Carlé, A., Andersen, S. L., Boelaert, K., & Laurberg, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0276 · Cited by 51
Syncope and Motor Vehicle Crash Risk: A Danish Nationwide Study
Numé, A.-K., Gislason, G., Christiansen, C. B., Zahir, D., Hlatky, M. A., Torp-Pedersen, C., & Ruwald, M. H. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8606 · Cited by 46
Self-citationSubclinical Hyperthyroidism: A Review of the Clinical Literature
Tsai, K., & Leung, A. M. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.02.002 · Cited by 45
Cardiovascular Disease and Thyroid Function
Faber, J. O., & Selmer, C. (2014) · Frontiers of hormone research · doi:10.1159/000360558 · Cited by 45
Self-citationThyroid disease in the perimenopause and postmenopause period
Uygur, M. M., Yoldemir, T., & Yavuz, D. G. (2018) · Climacteric · doi:10.1080/13697137.2018.1514004 · Cited by 45
Update on subclinical thyroid dysfunction
Hashimoto, K. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0182 · Cited by 44
Thyroid Hormone Therapy and Incident Stroke
Papaleontiou, M., Levine, D. A., Reyes-Gastelum, D., Hawley, S. T., Banerjee, M., & Haymart, M. R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab444 · Cited by 43
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Thijs, V. (2017) · Stroke · doi:10.1161/strokeaha.117.017083 · Cited by 43
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.004 · Cited by 42
Thvilum, M., Brandt, F., Brix, T. H., & Hegedűs, L. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1407 · Cited by 44
Tayal, B., Graff, C., Selmer, C., Kragholm, K. H., Kihlstrom, M., Nielsen, J. B., Olsen, A. S., Pietersen, A. H., Holst, A. G., Søgaard, P., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023854 · Cited by 41
Self-citationDifferentiated thyroid cancer—personalized therapies to prevent overtreatment
Luster, M., Weber, T., & Verburg, F. A. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.100 · Cited by 37
Kostopoulos, G., & Effraimidis, G. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0254 · Cited by 36
Elfenbein, D. M., Schaefer, S. C., Shumway, C., Chen, H., Sippel, R. S., & Schneider, D. F. (2015) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2015.10.005 · Cited by 34
Association of Thyroid Function Genetic Predictors With Atrial Fibrillation
Salem, J., Shoemaker, M. B., Bastarache, L. A., Shaffer, C. M., Glazer, A. M., Kroncke, B. M., Wells, Q. S., Shi, M., Straub, P., Jarvik, G. P., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2018.4615 · Cited by 34
Racial Differences in Atrial Fibrillation Epidemiology, Management, and Outcomes
Nanda, A. S., & Kabra, R. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0793-5 · Cited by 34
Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5)*
Grünwald, F., Schmidt, M. C., Schneider, P., Verburg, F. A., Luster, M., & Dietlein, M. (2016) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0823-16-04 · Cited by 33
Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021)
Liu, Y., Shan, Z., & Endocrine Metabolic Diseases Group of the Chinese Geriatrics Society (2021) · Aging Medicine · doi:10.1002/agm2.12165 · Cited by 33
Goldstein, S. A., Green, J., Huber, K., WOJDYLA, D. M., Lópes, R. D., Alexander, J. H., Vinereanu, D., Wallentin, L. C., Granger, C. B., & Al‐Khatib, S. M. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.046 · Cited by 32
Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism
Tribulová, N., Kurahara, L. H., Hlivák, P., Hirano, K., & Bačová, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082844 · Cited by 32
Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes
Schnabel, R. B., Pecen, L., Engler, D., Lucerna, M., Sellal, J., Ojeda, F., Caterina, R. D., & Kirchhof, P. F. (2018) · Heart · doi:10.1136/heartjnl-2017-312569 · Cited by 32
Associations between thyroid function and mortality: the influence of age
van de Ven, A. C., Netea-Maier, R. T., de Vegt, F., Ross, H. A., Sweep, F. C. G. J., Kiemeney, L. A., Smit, J. W., Hermus, A. R., & den Heijer, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1070 · Cited by 31
Singh, H., Shahid, M. Z., Harrison, S. L., Lane, D. A., Lip, G. Y. H., & Logantha, S. J. R. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296413 · Cited by 31
Hu, W., & Lin, C. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.036 · Cited by 31
Huang, M., Yang, S., Ge, G., Zhi, H., & Wang, L. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.05.008 · Cited by 31
Wongcharoen, W., Lin, Y., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Chung, F., Chong, E., Chao, T.-F., Tuan, T.-C., Chang, Y.-T., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.004 · Cited by 31
Cardiovascular and Neuronal Consequences of Thyroid Hormones Alterations in the Ischemic Stroke
Murolo, M., Vincenzo, O. D., Cicatiello, A. G., Scalfi, L., & Dentice, M. (2022) · Metabolites · doi:10.3390/metabo13010022 · Cited by 30
Ryödi, E., Salmi, J., Jaatinen, P., Huhtala, H., Saaristo, R., Välimäki, M. J., Auvinen, A. P., & Metso, S. (2013) · Clinical Endocrinology · doi:10.1111/cen.12359 · Cited by 30
Atrial Fibrillation Genetics Update: Toward Clinical Implementation
Kalstø, S. M., Siland, J. E., Rienstra, M., & Christophersen, I. E. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00127 · Cited by 28
The debate on treating subclinical hypothyroidism
Tan, E. (2016) · Singapore Medical Journal · doi:10.11622/smedj.2016165 · Cited by 29
Metadata
- Authors
- Selmer, C., Olesen, J. B., Hansen, M. L., Lindhardsen, J., Olsen, A.-M. S., Madsen, J. C., Faber, J., Hansen, P. R., Pedersen, O. D., Torp-Pedersen, C., & Gislason, G. H.
- Affiliations
- Gentofte Hospital (DK)
- University of Copenhagen (DK)
- Roskilde Sygehus (DK)
- Corresponding author
- Selmer, C.
- ORCID
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2012-11-27
- Volume
- 345
- Issue
- nov27 1
- Pages
- e7895-e7895
- ISSN
- 1756-1833 (ISSN-L)
- PMC
- PMC3508199
- OpenAlex
- W2015178517
- Cited by
- 323
- References
- 43
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 22 · 2023: 43 · 2022: 21 · 2021: 21 · 2020: 33 · 2019: 25 · 2018: 28 · 2017: 21 · 2016: 21 · 2015: 20 · 2014: 23 · 2013: 14 · 2012: 1
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- Hjerteforeningen
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- atrial fibrillation, thyroid dysfunction, thyroid-stimulating hormone, subclinical hyperthyroidism, overt hyperthyroidism, subclinical hypothyroidism, overt hypothyroidism, thyroid function, cardiovascular risk
- MeSH terms
- Atrial Fibrillation, Denmark, Female, Follow-Up Studies, Humans, Male, Middle Aged, Population Surveillance, Registries, Retrospective Studies, Risk Factors, Thyroid Diseases, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
